Zanubrutinib Combined with Rituximab and Methotrexate for Treatment of Primary Central Diffuse Large B-cell Lymphoma: A Case Report

Affiliations

LI Wenhui: Department of Hematology, the 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou 730000, China
WU Tao: Department of Hematology, the 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou 730000, China
CHEN Tianrong: Department of Hematology, the 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou 730000, China
LI Yunyun: Department of Hematology, the 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou 730000, China
LIU Wenhui: Department of Hematology, the 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou 730000, China
TIAN Hongjuan: Department of Hematology, the 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou 730000, China
ZHOU Rui: Department of Hematology, the 940th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Lanzhou 730000, China

Abstract

No abstracts available.

ISSN: 1000-8578 (Print)
Publisher: Magazine House of Cancer Research on Prevention and Treatment
Country of publisher: China
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.zlfzyj.com